Regression of established pulmonary metastases and subcutaneous tumor mediated by the systemic administration of high-dose recombinant interleukin 2
暂无分享,去创建一个
[1] A. Chang,et al. Systemic administration of recombinant human interleukin-2 in mice. , 1984, Journal of biological response modifiers.
[2] S. Rosenberg,et al. Adoptive immunotherapy of established pulmonary metastases with LAK cells and recombinant interleukin-2. , 1984, Science.
[3] S. Rosenberg,et al. Lymphokine-activated killer cells: lysis of fresh syngeneic natural killer-resistant murine tumor cells by lymphocytes cultured in interleukin 2. , 1984, Cancer research.
[4] A. Chang,et al. The systemic administration of purified interleukin 2 enhances the ability of sensitized murine lymphocytes to cure a disseminated syngeneic lymphoma. , 1984, Journal of immunology.
[5] M. Doyle,et al. Biological activity of recombinant human interleukin-2 produced in Escherichia coli. , 1984, Science.
[6] S. Rosenberg,et al. Successful immunotherapy of natural killer-resistant established pulmonary melanoma metastases by the intravenous adoptive transfer of syngeneic lymphocytes activated in vitro by interleukin 2 , 1984, The Journal of experimental medicine.
[7] K. Welte,et al. Purified human interleukin-2 enhances induction of immune interferon. , 1983, Cellular immunology.
[8] I. Kawase,et al. Interleukin 2 induces gamma-interferon production: participation of macrophages and NK-like cells. , 1983, Journal of immunology.
[9] S. Rosenberg,et al. IN VIVO ADMINISTRATION OF INTERLEUKIN‐2 ENHANCES SPECIFIC ALLOIMMUNE RESPONSES , 1983, Transplantation.
[10] S. Rosenberg,et al. The fate of interleukin-2 after in vivo administration. , 1983, Journal of immunology.
[11] S. Rosenberg,et al. Lymphokine-activated killer cell phenomenon. II. Precursor phenotype is serologically distinct from peripheral T lymphocytes, memory cytotoxic thymus-derived lymphocytes, and natural killer cells , 1983, The Journal of experimental medicine.
[12] R. Suzuki,et al. Natural killer (NK) cells as a responder to interleukin 2 (IL 2). II. IL 2-induced interferon gamma production. , 1983, Journal of immunology.
[13] C. Henney,et al. In vivo interleukin 2 administration augments the generation of alloreactive cytolytic T lymphocytes and resident natural killer cells. , 1983, Journal of immunology.
[14] T. Strom,et al. Restoration of allograft responsiveness in B rats by interleukin 2 and/or adherent cells. , 1982, Journal of Immunology.
[15] S. Rosenberg,et al. Lymphokine-activated killer cell phenomenon. Lysis of natural killer- resistant fresh solid tumor cells by interleukin 2-activated autologous human peripheral blood lymphocytes , 1982, The Journal of experimental medicine.
[16] P. Greenberg,et al. Augmentation of the anti-tumor therapeutic efficacy of long-term cultured T lymphocytes by in vivo administration of purified interleukin 2 , 1982, The Journal of experimental medicine.
[17] S. Rosenberg,et al. Lysis of fresh human solid tumors by autologous lymphocytes activated in vitro with lectins. , 1982, Cancer research.
[18] S. Rosenberg,et al. Lysis of fresh and cultured autologous tumor by human lymphocytes cultured in T-cell growth factor. , 1981, Cancer research.
[19] A. Munck,et al. T cell growth factor receptors. Quantitation, specificity, and biological relevance , 1981, The Journal of experimental medicine.
[20] Y. S. Choi,et al. Recovery of the in vivo cytotoxic T-cell response in cyclophosphamide-treated mice by injection of mixed-lymphocyte-culture supernatants. , 1981, Cancer research.
[21] S. Rosenberg,et al. Lysis of human solid tumors by autologous cells sensitized in vitro to alloantigens. , 1981, Journal of immunology.
[22] T. Diamantstein,et al. Interleukin-2 allows in vivo induction of anti-erythrocyte autoantibody production in nude mice associated with the injection of rat erythrocytes. , 1981, Clinical and experimental immunology.
[23] E. Rüde,et al. T cell factor (interleukin 2) allows in vivo induction of T helper cells against heterologous erythrocytes in athymic (nu/nu) mice , 1980, European journal of immunology.
[24] S. Rosenberg,et al. In vitro growth of murine T cells. V. The isolation and growth of lymphoid cells infiltrating syngeneic solid tumors. , 1980, Journal of immunology.
[25] K. Heeg,et al. T-cell-derived helper factor allows in vivo induction of cytotoxic T cells in nu/nu mice , 1980, Nature.
[26] S. Rosenberg,et al. In vitro growth of murine T cells. I. Production of factors necessary for T cell growth. , 1978, Journal of immunology.
[27] F. Bach,et al. Generation of cytotoxic T lymphocytes to autologous human leukaemia cells by sensitisation to pooled allogeneic normal cells , 1978, Nature.
[28] S. Golub,et al. Fetal calf serum-induced blastogenic and cytotoxic responses of human lymphocytes. , 1976, Cancer research.
[29] R. Gallo,et al. Selective in vitro growth of T lymphocytes from normal human bone marrows. , 1976, Science.
[30] H. Wexler. Accurate identification of experimental pulmonary metastases. , 1966, Journal of the National Cancer Institute.
[31] E. Gehan. A GENERALIZED WILCOXON TEST FOR COMPARING ARBITRARILY SINGLY-CENSORED SAMPLES. , 1965, Biometrika.